2020
DOI: 10.1016/j.ejca.2019.11.002
|View full text |Cite
|
Sign up to set email alerts
|

Nationwide trends in incidence, treatment and survival of pancreatic ductal adenocarcinoma

Abstract: Background:

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
2
1

Citation Types

6
107
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
7
1

Relationship

4
4

Authors

Journals

citations
Cited by 113 publications
(113 citation statements)
references
References 35 publications
(28 reference statements)
6
107
0
Order By: Relevance
“…Pancreatic cancer is one of the leading causes of cancerrelated death in developed countries, and its incidence is increasing. 1 Although progress has been made in treatment options, the 5-year survival rate remains poor regardless of disease state. 2 Pancreatoduodenectomy is the only potential curative treatment option for patients with suspected pancreatic ductal adenocarcinoma (PDAC).…”
Section: Discussionmentioning
confidence: 99%
See 1 more Smart Citation
“…Pancreatic cancer is one of the leading causes of cancerrelated death in developed countries, and its incidence is increasing. 1 Although progress has been made in treatment options, the 5-year survival rate remains poor regardless of disease state. 2 Pancreatoduodenectomy is the only potential curative treatment option for patients with suspected pancreatic ductal adenocarcinoma (PDAC).…”
Section: Discussionmentioning
confidence: 99%
“…Patients with PALN metastasis resembled only one-fifth of the population who were selected for resection, which in turn is only one-sixth of patients who present with PDAC. 1 Second, the retrospective design of the study has its known limitations. Complications were only assessed based on the available medical records.…”
Section: Discussionmentioning
confidence: 99%
“…There are several cancer types and stages for which survival rates have improved, including, for example, local-stage esophageal cancer; regional-stage female breast and colorectal cancer; and distant-stage non-Hodgkin lymphoma (Jemal et al, 2017). Improved surgical techniques and the centralization of surgical procedures in many countries have likely played a major role in the improved outcome for localized cancers (Latenstein et al, 2020;van Putten et al, 2018). Locally advanced cancers have mostly benefited from the increased use of combined multimodality approaches, including radiotherapy and chemotherapy (Berry et al, 2005;Brenner et al, 2012;Latenstein et al, 2020;Sant et al, 2006).…”
Section: Radiation Oncology and Recent Progress In Cancer Treatmentmentioning
confidence: 99%
“…However, these data were based primarily on surgical series or registry data. Considering that it has been reported that approximately 80% of PC patients were diagnosed at unresectable stages [9,10], the majority of UC cases potentially have metastases. However, previous reports have rarely mentioned unresectable stage disease, and clinical and treatment data for patients with unresectable UC are lacking.…”
Section: Introductionmentioning
confidence: 99%